The Corporate Liaison Board (CLB) forges a partnership between the Endocrine Society and senior executives in industry. It is a unique consortium of thought leaders and stakeholders assembled to discuss ideas and goals for the future of endocrinology.
Leaders from companies who have experience in the field provides vital perspective to the Endocrine Society’s overarching mission. Through participation in the CLB, members have a forum to share their perspective with the Endocrine Society leaders represents on issues, such as clinical education, healthcare legislation, or patient education. Additionally, members have access to an array of benefits while showing leadership within in their fields.
If you have a question about your membership or are interested in joining the Corporate Liaison Board, please email us at development@endocrine.org or call us at 202-971-3636.
The Corporate Liaison Board (CLB) supports the Endocrine Society mission of advancing patient care by:
Professor Demeneix has been a tireless scientist and advocate for more protective policies that will improve public and ecological health. We thank her for her leadership and dedication!
Bringing together leading experts, researchers, and the most respected clinicians in the field, ENDO represents a convergence of science and practice that highlights and facilitates breakthrough discoveries in the field of endocrinology.